Weiss Ratings Reiterates Sell (E+) Rating for China SXT Pharmaceuticals (NASDAQ:SXTC)

Key Points

• Weiss Ratings has reiterated a "sell (E+)" rating for China SXT Pharmaceuticals (NASDAQ:SXTC) following a recent analysis.
• In contrast, Wall Street Zen has upgraded China SXT Pharmaceuticals from a "sell" rating to a "hold" rating, indicating mixed sentiments about the stock.
• Currently, China SXT Pharmaceuticals' stock price is flat at $1.34, with an average rating of "Sell" according to MarketBeat data.

China SXT Pharmaceuticals (NASDAQ:SXTC - Get Free Report)'s stock had its "sell (e+)" rating restated by equities research analysts at Weiss Ratings in a report issued on Friday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded shares of China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday, August 2nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, China SXT Pharmaceuticals presently has an average rating of "Sell".

China SXT Pharmaceuticals Stock Performance

Shares of NASDAQ SXTC remained flat at $1.34 during trading on Friday. 43,259 shares of the stock traded hands, compared to its average volume of 22,525. China SXT Pharmaceuticals has a 12-month low of $0.95 and a 12-month high of $7.84. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.54 and a quick ratio of 3.40. The company's 50 day moving average price is $1.58 and its two-hundred day moving average price is $1.71.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.